ML17093A661
From kanterella
Revision as of 13:41, 17 November 2017 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
| ML17093A661 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 03/06/2017 |
| From: | Haass C C Northwest Medical Isotopes |
| To: | Balazik M F Document Control Desk, Office of Nuclear Reactor Regulation |
| References | |
| NWMI-LTR-2017-001, TAC MF6138 | |
| Download: ML17093A661 (22) | |
Similar Documents at Northwest Medical Isotopes | |
|---|---|
Category:Letter
MONTHYEARML22147A1572022-07-11011 July 2022
[Table view]Northwest Medical Isotopes, LLC - Termination of Construction Permit CPMIF-002 ML22084A0042022-02-0707 February 2022 Northwest Medical Isotopes, LLC (Nwmi), Request for Termination of Construction Permit No. CPMIF-002 ML19315A0132019-11-11011 November 2019 Northwest Medical Isotopes, LLC (Nwmi) Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 (Docket No. 50-609), November 11, 2019 ML18163A0612018-11-16016 November 2018 Letter: Approval of Request for Exemption from Requirements of Title 10 of the Code of Federal Regulations, Paragraph 70.21 (F) ML18318A3052018-11-0909 November 2018 Northwest Medical Isotopes, LLC (Nwmi) - Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 ML18113A5042018-05-17017 May 2018 Letter to L. Tippet-Mosby Missouri Department of Natural Resources Request for Comments on North West Medical Isotopes Draft Environmental Assessment ML18037A3082018-05-0909 May 2018 Northwest Medical Isotopes, LLC - Transmittal Letter Regarding Issuance of Construction Permit for a Medical Radioisotope Production Facility ML18110A6072018-04-26026 April 2018 Acceptance for Review of Request for Exemption from Requirements of 10 CFR 70.21(F) for the Target Fabrication Portion of the Northwest Medical Isotopes Radioisotope Production Facility ML18088A1752018-03-12012 March 2018 Supplemental Information Request - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(F), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility ML17355A5292017-12-21021 December 2017 RIC Invitation Letter External Speaker 2018 Haass ML17362A0402017-12-18018 December 2017 Northwest Medical Isotopes, LLC - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70 21(F), Filing. ML17353A0982017-12-18018 December 2017 Letter from Missouri Department of Natural Resources Regarding Northwest Medical Isotopes, LLC Application for Construction Permit ML17349A1732017-12-14014 December 2017 Letter to Chairman Kristine Svinicki from Senators Ron Wyden and Claire Mccaskill Regarding Northwest Medical Isotopes, LLC Application for Construction Permit ML17324A4122017-12-0808 December 2017 LTR-17-0431-1 - Report on Safety Aspects of the Construction Permit Application for Nwmi Medical Radioisotope Production Facility ML17339A1972017-11-27027 November 2017 11-27-17 Ltr to Maurice Graham, Et Al., from Annette Vietti-Cook Notifying Him of That the Commission Is Convening an Evidentiary Hearing on the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facilit ML17332A6802017-11-24024 November 2017 11-24-17, Ltr to the Honorable Eric Greitens Et Al., Governor of Missouri from Denise Mcgovern Notifying Him of an Evidentiary Hearing for the Construction Permit Application Associated with Proposed Northwest Medical Isotopes Facility in C ML17331B4452017-11-22022 November 2017 11-22-17 Letter to Bill Anoatubby Et Al, Governor, Chickasaw Nation from Annette Vietti-Cook Notifying Him of the Evidentiary Hearing for the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facility i ML17310A3662017-11-16016 November 2017 Transmittal Letter of Safety Evaluation Report for the Northwest Medical Isotopes, LLC, Constuction Permit Application ML17310B5112017-11-0606 November 2017 Report on the Safety Aspects of the Construction Permit for Northwest Medical Isotopes, LLC, Radioisotope Production Facility ML17283A1092017-09-28028 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017 ML17283A1082017-09-28028 September 2017 Responses to Advisory Committee on Reactor Safeguards Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMl-2013-021, Construction Permit Application for Radioisotope Production, at Meeting on September 21, 2017 ML17262A1112017-09-21021 September 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit ML17265A0462017-09-19019 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit ML17265A0482017-09-18018 September 2017 Responses to Advisory Committee on Reactor Safeguard Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMI-2013-021, Construction Permit Application/Or Radioisotope Production, at Meetings on June 19, 2017; July 11, 2017; & ML17268A3032017-09-15015 September 2017 Ltr from Missouri Dept of Natural Resources Dtd Sep 15, 2017, to Nwmi, Issuing 401 Water Quality Certification ML17221A1992017-08-0707 August 2017 Transmittal of Revision 1 of Chapters 10.0, 11.0, 12.0 (Including Appendices 12A, 12b and 12C) and 14.0 and Revision 2 of Chapters 2.0, 3.0, 6.0, 7.0, 8.0 and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Productio ML17193A4252017-07-0606 July 2017 Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 3.0, 6.0, 7.0, 8.0, 9.0, and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Production ML17158B2672017-06-0303 June 2017 Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 1.0, 2.0, 4.0, and 5.0 of NWMl-2013-021, Construction Permit Application for Radioisotope Production Facility ML17157B4112017-06-0202 June 2017 Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections ML17111A7252017-05-30030 May 2017 Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, LLC Construction Permit Application ML17086A5822017-05-30030 May 2017 Letter from NRC to Nwmi Carolyn Haass Transmitting Nwmi Final EIS ML17132A3912017-05-24024 May 2017 Notice of Availability of the Final Environmental Impact Statement for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility Construction Permit ML17096A1832017-05-23023 May 2017 Notice of Availability of the Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application (CAC No. MF6135) to N. Fowler ML17114A2532017-05-22022 May 2017 Final EIS for Nwmi Construction Permit and Response to Comments on the Draft EIS from EPA ML17121A3562017-05-22022 May 2017 Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement ML17128A0652017-04-28028 April 2017 Northwest Medical Isotopes, LLC Responses to the NRC Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17128A0662017-04-28028 April 2017 Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017) ML17069A4082017-03-29029 March 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit ML17061A1592017-03-22022 March 2017 Proprietary Determination Regarding Northwest Medical Isotopes Presentation November 10, 2016 ML17093A6612017-03-0606 March 2017 Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17048A2712017-02-27027 February 2017 Northwest Medical Isotopes, LLC - Proprietary Determination Regarding Request for Information Responses Dated November 28, 2016 ML16344A0522016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information ML16305A2442016-11-10010 November 2016 Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, Llc Construction Permit Application ML16294A1352016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility ML16293A8812016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility ML16308A4342016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, Llc Radioisotope Production Facility Construction Permit Application (Cac No. MF6135) ML16295A1292016-11-0404 November 2016 Notice of Availability of Nwmi DEIS-Tribal ML16272A2942016-11-0101 November 2016 NRC to FWS Availability of the NWMI Draft EIS and Concurrence with ESA Determinations ML16294A4792016-11-0101 November 2016 Letter to Nicholas Fowler, Nwmi, Transmitting the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application ML16292A7242016-11-0101 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application 2022-07-11 Category:Response to Request for Additional Information (RAI) MONTHYEARML17283A1092017-09-28028 September 2017
[Table view]Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017 ML17265A0462017-09-19019 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit ML17265A0472017-09-19019 September 2017 Response to the U.S. Nuclear Regulatory Commission, Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Preliminary Safety Analysis Report, Construction Permit Application ML17265A0482017-09-18018 September 2017 Responses to Advisory Committee on Reactor Safeguard Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMI-2013-021, Construction Permit Application/Or Radioisotope Production, at Meetings on June 19, 2017; July 11, 2017; & ML17128A0672017-04-28028 April 2017 NWMI-2017-RAI-002, Rev. 0, Response to the U.S. Nuclear Regulatory Commission Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit (TAC MF6138). ML17128A0662017-04-28028 April 2017 Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017) ML17128A0652017-04-28028 April 2017 Northwest Medical Isotopes, LLC Responses to the NRC Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17093A6612017-03-0606 March 2017 Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017 ML16344A0532016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information Regarding the Preliminary Safety Analysis Report and Environmental Review ML16270A3772016-09-0101 September 2016 Northwest Medical Isotopes, LLC, Response to Environmental Request for Additional Information - Additional Clarification on POSA3-1A, POSA3-2A, POSA3-3A, NOI3-IB, and PA3-1 ML16210A3052016-07-18018 July 2016 Northwest Medical Isotopes, LLC, Response to Request for Additional Information Regarding Chapters 4, 13, and 19 of the Preliminary Safety Analysis Report and Environmental Review ML16124A5102016-05-26026 May 2016 Summary of Telephone Conference Call Held on April 21, 2016, Between the U.S. Nuclear Regulatory Commission and Northwest Medical Isotopes, LLC Concerning Clarifications on Responses to Request for Additional Information for the Environment ML16123A1192016-04-25025 April 2016 Northwest Medical Isotopes, LLC - Responses to the NRC Environmental Request for Additional Information - Letter Dated March 28, 2016 ML16053A2042016-02-12012 February 2016 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 19, 2016 ML15328A0712015-11-20020 November 2015 Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information, Environmental Review of the Construction Permit Application, Including Document No. NWMI-2015-RAI-001. Part 1 of 14 ML15328A0702015-11-20020 November 2015 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated November 2, 2015 2017-09-28 |
Retrieved from "https://kanterella.com/w/index.php?title=ML17093A661&oldid=190403"